Losartan reverses glomerular podocytes injury induced by AngII via stabilizing the expression of GLUT1

Molecular Biology Reports

Volumn 40, Issue 11, 2013, Pages 6295-6301

  Yu, S Y ^a   Qi, R ^a   Zhao, H ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b ANHUI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

AngII; GLUT1; Losartan; Podocyte

Indexed keywords

ANGIOTENSIN II; GLUCOSE TRANSPORTER 1; LOSARTAN; MESSENGER RNA;

ALBUMINURIA; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL IMMORTALIZATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; DRUG ACTIVITY; GENE OVEREXPRESSION; GLOMERULAR PODOCYTE INJURY; GLOMERULOPATHY; GLUCOSE TRANSPORT; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PODOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 1; HUMANS; LOSARTAN; PODOCYTES; RNA, MESSENGER; TIME FACTORS;

EID: 84892694611     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2742-9     Document Type: Article

References (21)

1. Siu B, Saha J, Smoyer WE, Sullivan KA, Brosius FC 3rd (2006) Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol 7:6
2. Susztak K, Raff AC, Schiffer M, Bottinger EP (2006) Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55:225-233
3. Fredersdorf S, Weil J, Ulucan C, Birner C, Buttner R, Schubert T, Boger CA, Debl K, Muders F, Riegger GA, luchner A (2007) Vasopeptidase inhibition attenuates proteinuria and podocyte injury in zucker diabetic fatty rats. Naunyn Schmiedebergs Arch Pharmacol 375:95-103
4. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99:342-348
5. Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Corat MA, Zeier M, Blessing E, Oh J, Gerlitz B, Berg DT, Grinnell BW, Chavakis T, Esmon CT, Weiler H, Bierhaus A, Nawroth PP (2007) Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 13:1349-1358
6. Susztak K, Raff AC, Schiffer M, Bottinger EP (2006) Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55:225-233
7. Meyer TW, Bennett PH, Nelson RG (1999) Podocyte number predicts longterm urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 42: 1341-1344
8. Breyer MD, Bottinger E, Brosius FC, Coffman TM, Harris RC, Heilig CW, Sharma K (2005) Mouse models of diabetic nephropathy. J Am Soc Nephrol 16:27-45
9. Wolf G, Chen S, Ziyadeh FN (2005) Perspectives in diabetes: from the periphery of the glomerular capillary wall toward the center of disease, podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626-1634
10. Siu B, Saha J, Smoyer WE et al (2006) Reductioninpodocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC nephrology 7(1):6
11. Taal MW, Brenner BM (2002) Combination ACEI and ARB therapy: additional benefit in renoprotection? Curr Opin Nephrol Hypertens 11:377-381
12. Taal MW, Brenner BM (2001) Achieving maximal renal protection in nondiabetic chronic renal disease. Am J Kidney Dis 38:1365-1371
13. Brenner BM, Zagrobelny J (2003) Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-convertingenzyme inhibitors. Kidney Int Suppl 83:S77-S85
14. Brenner BM, Lawler EV, Mackenzie HS (1996) The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 49:1774-1777
15. Yu SY, Qi R (2013) Role of bad in podocyte apoptosis induced by puromycin aminonucleoside. Transplant Proc 2:569-573
16. Hostetter TH, Olson JL, Rennke HG et al (1981) Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241:F85-F93
17. Cheng H, Zhang M, Moeckel GW et al (2005) Expression of mediators of renal injury in the remnant kidney of ROP mice is attenuated by cyclooxygenase-2 inhibition. Nephron Exp Nephrol 101(3):e75-e85
18. Fauvel JP, Velon S, Berra N, Pozet N, Madonna O, Zech P, Laville M (1996) Effects of losartan on renal function in patients with essential hypertension. J Cardiovasc Pharmacol 28:259-263
19. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G (1990) Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85:541-549
20. Linfeng Sun et al (2012) Crystal structure of a bacterial homo-logue of glucose transporters GLUT1-4. Nature 490:361-366
21. Wenpeng Cui et al (2012) Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis. Mol Biol Rep 39:8551-8558